OCGN - good buy, WHO approval waitingGood buy at this price.
Waiting for WHO approval for Covid Vaccine, it's partially approved for emergency use in India.
OCGN trade ideas
$OCGN Daily Chartdaily chart building higher lows although bullish triangle pattern, still hanging around at bottom, needs to move up and build higher highs.
OCGN next movementsWe arribe to the final countdown and go up... If the news are good the movement will be bullish.
I show you my prediction lines:
Blue -> Hard Resistance that if overcome will become hard support.
Red -> Resistance that if overcome will become support.
Orange -> Bearish trend that we broke days ago and that we do not want to see any more.
Good luck to all!
OCGN -> $10 magnetOnly worry right now is the small trendline and seeing a sudden reversal, but there is bullish flow and it seems like its going to break into 10.14. I would be carefull if it breaks below the support near 7
$OCGN WedgeWanted to get thoughts on $OCGN. I have been tracking this for some time and looks like this wedge is ready to break out. I've been on the sidelines with this one and wanted to get some input.
OcugenA very interesting chart. 5000+% healthy digestion. Long flag.
News triggers on the horizon - in 4-6 weeks?
Emergency authorization to WHO on July 09.
Full use application to US later this year?
keeping an eye on because of the great potential and risk-reward
ocgni don't have position yet
i transfered all my founds to sesen
i think the news at ocgn will come mind-end of September
$ocgn #ocugen strong longwe broke out 21ma today and tomorrow we will break 50ma and full uptrend to above $20
$ocgn #ocugen out of downtrend line now and waiting approval we are out of the downtrend line and we are waiting the next weeks for vaccine approval from who and canada will be the first country which buy it
OCGN Ocugen new Covid-19 Vaccine and Price TargetOCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.
With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.
My short term Price Target is 10.30usd
OCGNInteresting to say the least. Digging the apparent repetition here. Those downtrend lines are clones. Next friday $10 calls for a little lotto play seems like a decent risk/reward.
Break out!!! OCGN is going to break the triangle and should watch for the volume buy-in for an entry here. Watch MACD+AO turn green for confirmation.
Covid StocksOCGN looks interesting at this entry point with excellent risk reward. Looks like starting Wave 3 today.
OCGN breaking outOCGN breaking out from the trendline. Hopefully, it's not a fake break out. Aug 20th 15 call options are only .18c.
OCUGEN to make new highs before end of JulyThe new TOP should come as early as July 24 which means we can shoot up anytime now.
This looks like a solid bullish trend for OCGN NASDAQ:OCGN This looks like a solid long play, the support line has been tested multiple times.
OCGN back to basicsOCGN kind of treading water for now. I think what we need to see are some rock-solid results from COVAXIN, which this rolling submission could be helpful in identifying. The Phase 3 results were interesting. With more warnings coming out about the current SOC EAU vaccines, another option might not be "too late" at this point. But a lot will clearly come down to the results. For now, speculation is probably playing a bigger role as we don't know much more beyond what Ocugen announced this week. Regardless, looking at chart levels, a quick Fib retracement shows a few "pain points" on the chart, namely the 618 fib that has been a frequent resistance level over the last few months.
"On July 2nd, Ocugen reported new evidence from Bharat Biotech. The company shared positive results of its Phase 3 study of COVAXIN™; a whole virion inactivated COVID-19 vaccine candidate. According to the company, it demonstrated a vaccine efficacy in mild, moderate, and severe COVID-19 disease of 77.8% with efficacy against severe COVID-19 disease alone of 93.4%.
“With the Delta variant becoming a dominant strain of COVID-19 in the United States, we believe that the Phase 3 efficacy results reported by Bharat Biotech demonstrate that COVAXIN™ has the potential to become an important option to expand protection against this emerging variant. Combining these data with the only Delta-variant results from a controlled Phase 3 clinical trial, evidence continues to support a favorable benefit-risk profile for COVAXIN™.” - Dr. Bruce Forrest, Acting Chief Medical Officer and a member of the vaccine scientific advisory board of Ocugen. "
Quote Source: 7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
$OCGN is gonna fall todayPupm&Dump trading strategy idea.
$OCGN is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $8,48;
stop-loss — $9,07;
take-profit — $7,32.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
OCGN about to break outOCGN is going to break out the triangle and running before the ER (watch TTM change color from yellow to green) and gonna drop hard before ER.
